High-grade pleomorphic rhabdomyosarcoma in a 60-year-old male: a case report and review of the literature.
Fadi TazaArjun S KanwalMary ZultySadaf MustafaPublished in: Journal of community hospital internal medicine perspectives (2020)
Rhabdomyosarcoma is an aggressive malignant soft-tissue sarcoma that develop from undifferentiated mesenchymal cells. Less than 1% of all adult solid malignant cancers are sarcomas, and RMSs represent less than 2-5% of adult sarcomas. RMS is divided into three main subtypes: Embryonal, alveolar and pleomorphic RMS (PRMS). Most common subtype in adults is PRMS. Most common primary sites are extremities, trunk wall, and genitourinary organs. Metastasis are often found at diagnosis. 5-year overall survival rates were reported in the Surveillance, Epidemiology, and End Results database (SEER) to be 63% for pediatric patients and 27% for adults. Given the rarity of the adult PRMS, variation in its clinical presentation, characteristics of the tumor itself and the prognosis; there are very limited data available to guide the management of adults with PRMS. Herein we present a case report of pleomorphic rhabdomyosarcoma of the right thigh in a 60-year-old male who achieved a long-term survival (30 months) which was accomplished by multimodality treatment including surgery, radiotherapy, and chemotherapy. .
Keyphrases
- high grade
- low grade
- induced apoptosis
- locally advanced
- stem cells
- minimally invasive
- public health
- bone marrow
- radiation therapy
- electronic health record
- early stage
- soft tissue
- squamous cell carcinoma
- emergency department
- coronary artery bypass
- cell cycle arrest
- radiation induced
- machine learning
- free survival
- oxidative stress
- cell death
- deep learning
- adverse drug
- rectal cancer
- data analysis